145 related articles for article (PubMed ID: 18720234)
1. Preparation and characterization of salt forms of enalapril.
Kumar L; Amin A; Bansal AK
Pharm Dev Technol; 2008; 13(5):345-57. PubMed ID: 18720234
[TBL] [Abstract][Full Text] [Related]
2. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
[TBL] [Abstract][Full Text] [Related]
3. Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole.
Paulekuhn GS; Dressman JB; Saal C
Pharmazie; 2013 Jul; 68(7):555-64. PubMed ID: 23923637
[TBL] [Abstract][Full Text] [Related]
4. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
[TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
Sosnowska K; Winnicka K; Czajkowska-Kośnik A
Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
[TBL] [Abstract][Full Text] [Related]
6. Structure determination of enalapril maleate form II from high-resolution X-ray powder diffraction data.
Kiang YH; Huq A; Stephens PW; Xu W
J Pharm Sci; 2003 Sep; 92(9):1844-53. PubMed ID: 12950002
[TBL] [Abstract][Full Text] [Related]
7. Effect of stearic acid on enalapril stability and dissolution from multiparticulate solid dosage forms.
Cunha TA; Serpa RC; de Oliveira AP; Nasser LN; de Freitas LA; Taveira SF; Diniz DG; Lima EM; Marreto RN
AAPS PharmSciTech; 2013 Sep; 14(3):1150-7. PubMed ID: 23897034
[TBL] [Abstract][Full Text] [Related]
8. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
Lima DM; dos Santos LD; Lima EM
J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
[TBL] [Abstract][Full Text] [Related]
9. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
10. Salt Engineering of Aripiprazole with Polycarboxylic Acids to Improve Physicochemical Properties.
Afrooz H; Mohamed EM; Barakh Ali SF; Dharani S; Nutan MTH; Khan MA; Rahman Z
AAPS PharmSciTech; 2021 Jan; 22(1):31. PubMed ID: 33405012
[TBL] [Abstract][Full Text] [Related]
11. Effect of counterions on physicochemical properties of prazosin salts.
Kumar L; Meena CL; Pawar YB; Wahlang B; Tikoo K; Jain R; Bansal AK
AAPS PharmSciTech; 2013 Mar; 14(1):141-50. PubMed ID: 23250707
[TBL] [Abstract][Full Text] [Related]
12. Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril.
Verbeeck RK; Kanfer I; Löbenberg R; Abrahamsson B; Cristofoletti R; Groot DW; Langguth P; Polli JE; Parr A; Shah VP; Mehta M; Dressman JB
J Pharm Sci; 2017 Aug; 106(8):1933-1943. PubMed ID: 28435140
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties.
Hamideh A; Rahman Z; Dharani S; Khuroo T; Mohamed EM; Nutan MTH; Reddy IK; Khan MA
Pharm Dev Technol; 2021 Apr; 26(4):455-463. PubMed ID: 33653226
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of stability of enalapril maleate in solid phase.
Stanisz B
J Pharm Biomed Anal; 2003 Feb; 31(2):375-80. PubMed ID: 12609677
[TBL] [Abstract][Full Text] [Related]
15. Stability of enalapril maleate in three extemporaneously prepared oral liquids.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1998 Jun; 55(11):1155-7. PubMed ID: 9626379
[TBL] [Abstract][Full Text] [Related]
16. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
17. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
Eyjolfsson R
Pharmazie; 2002 May; 57(5):347-8. PubMed ID: 12061263
[No Abstract] [Full Text] [Related]
18. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
19. Urea inclusion compounds of enalapril maleate for the improvement of pharmaceutical characteristics.
Thakral S; Madan AK
J Pharm Pharmacol; 2007 Nov; 59(11):1501-7. PubMed ID: 17976260
[TBL] [Abstract][Full Text] [Related]
20. Enalapril maleate form II: stabilization in a tablet formulation.
Eyjolfsson R
Pharmazie; 2003 May; 58(5):357. PubMed ID: 12779058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
